Back

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON)

26 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Ingrid Cardells Beltran

Hospital de Manises, Valencia (Spain)

67 More presentations in this session

Presentation thumbnail
Slides
Presentation thumbnail
Presentation thumbnail
Doctor E. Repasos (Athens, GR)
Presentation thumbnail
Doctor A. Ntalianis (Athens, GR)
Presentation thumbnail
Professor T. Jaarsma (Linkoping, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

26 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Moving targets of treatment in heart failure
20 May 2025
thumbnail
Congress Presentation
The IIISAS trial: a randomized controlled trial designed to assess the effect of ferric derisomaltose on physical capacity in patients with aortic stenosis and iron deficiency undergoing TAVI
29 June 2021
thumbnail
Congress Presentation
Admission ferritin in STEMI predicts long-term major adverse cardiovascular outcomes
15 March 2025
thumbnail
Congress Presentation
Iron chelation therapy failed to improve cardiac dysfunction caused by mitochondrial injury in rats with iron overload cardiomyopathy a 7T Cardiac MR research in vivo
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources